We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MSFT icon
Microsoft
MSFT
+$205M
3
TSLA icon
Tesla
TSLA
+$83.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$65.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$64.9M

Top Sells

Rank Stock Value
1
SQM icon
Sociedad Química y Minera de Chile
SQM
+$60.4M
2
META icon
Meta Platforms (Facebook)
META
+$39.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$36.9M
4
BKNG icon
Booking.com
BKNG
+$28M
5
SYK icon
Stryker
SYK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
101
Exelixis
EXEL
$14B
$32.5M 0.23%
2,070,953
+165,409
+9% +$3.2M
CDNS icon
102
Cadence Design Systems
CDNS
$93.4B
$32.4M 0.23%
198,352
+33,203
+20% +$5.71M
BMY icon
103
Bristol-Myers Squibb
BMY
$128B
$31.4M 0.22%
441,111
+169,594
+62% +$12.3M
BALL icon
104
Ball Corp
BALL
$17.2B
$30.5M 0.21%
630,597
+19,386
+3% +$1.19M
KEYS icon
105
Keysight
KEYS
$53.6B
$30.4M 0.21%
192,903
+17,567
+10% +$2.81M
AZO icon
106
AutoZone
AZO
$50.2B
$29.2M 0.21%
13,643
+2,179
+19% +$4.75M
TTEK icon
107
Tetra Tech
TTEK
$8.28B
$29.2M 0.21%
1,136,180
+104,480
+10% +$2.92M
BNTX icon
108
BioNTech
BNTX
$23B
$29.1M 0.21%
215,416
-22,718
-10% -$3.47M
MRNA icon
109
Moderna
MRNA
$22.1B
$29.1M 0.2%
245,899
+110,425
+82% +$16.8M
NBIX icon
110
Neurocrine Biosciences
NBIX
$17.7B
$28.8M 0.2%
271,481
-59,448
-18% -$6.03M
NEE icon
111
NextEra Energy
NEE
$185B
$28.7M 0.2%
366,072
-117,561
-24% -$9.97M
LULU icon
112
lululemon athletica
LULU
$13.4B
$28.7M 0.2%
102,548
+39,043
+61% +$12.1M
BCYC
113
Bicycle Therapeutics
BCYC
$276M
$28.7M 0.2%
1,232,254
+397,578
+48% +$9.46M
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.6B
$28.2M 0.2%
332,895
-58,735
-15% -$5.23M
MMM icon
115
3M
MMM
$91.9B
$28.2M 0.2%
304,850
+57,892
+23% +$6.35M
ENPH icon
116
Enphase Energy
ENPH
$5.01B
$27.7M 0.2%
99,855
-21,629
-18% -$5.83M
CNC icon
117
Centene
CNC
$31.6B
$27.6M 0.19%
355,300
+309,382
+674% +$27.6M
XENE icon
118
Xenon Pharmaceuticals
XENE
$6.36B
$27.5M 0.19%
760,884
-102,256
-12% -$3.68M
MET icon
119
MetLife
MET
$61.2B
$26.8M 0.19%
441,528
+265,366
+151% +$17M
INTU icon
120
Intuit
INTU
$83.1B
$26.8M 0.19%
69,242
-17,599
-20% -$7.6M
INVH icon
121
Invitation Homes
INVH
$17.6B
$26.4M 0.19%
782,609
+92,158
+13% +$3.42M
BBY icon
122
Best Buy
BBY
$18.6B
$26M 0.18%
410,426
+318,884
+348% +$23.6M
RLAY icon
123
Relay Therapeutics
RLAY
$4.06B
$25.9M 0.18%
1,159,421
+601,604
+108% +$13.2M
HALO icon
124
Halozyme
HALO
$9.66B
$25.8M 0.18%
653,675
+71,178
+12% +$3.15M
SEDG icon
125
SolarEdge
SEDG
$2.62B
$25.8M 0.18%
111,621
+18,006
+19% +$5.31M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.